Pinned Tweet
The market hasn't been oversold this bad since COVID crash of 2020. Arguably market was not expecting another war and it is getting priced in. No one knows, what will be the consequences of US Iran conflict and when will the Crude price stabilize?
Similar sentiments were there in 2020, when global lockdown happened during Covid. That time it seemed most businesses would shut or report huge losses. What actually followed was longest bull run in recent times, exceeding the expectations of all and sundry.
Those who were pessimistic paid huge opportunity cost that time.
Stock price would always follow the earnings growth momentum, come want may. With at least 2 year time frame, this fall is another great opportunity to accumulate quality companies with PEG ratio of around 0.5. Many opportunities exist in this range today.
Lastly, I will not be biased this time that only small caps can generate alpha. I am not ignoring quality mid and large caps.
Tonbo Imaging has received a supply order from the Ministry of Defence, Government of India
Order value: approx. INR 35.62 crore (inclusive of taxes)
Scope: clip-on thermal weapon sights for assault rifles + associated support equipment
Deliveries in two lots within 52 weeks from the effective date;
Foreign portfolio investors (FPIs) have net purchased a record $10.07B into Indian equities this month, till November 17. This is the highest net FPI equity inflows in a month.
The inflows have surpassed the previous monthly record of $8.42B in December 2020, by 19.6%.
thehindubusinessline.com/dat…
If macros are so bad like there is no tomorrow, then why FIIs are buying.
More importantly who is selling to FIIs?
2
4
1,317
Caught 3 PEADS in this results season with good returns and falled in two
🟩 IGIL & Tonbo Imaging - bought after results, both rallied 25-30%
🟩 MSTC - bought before results in anticipation of good nos.
🟥 Hindustan Copper - bought after results and exited in loss same day
🟥 Morepen Labs - bought before results and rest is history
38
4,992
Guidance of selective high quality SMEs as per H1 results and concalls
Great efforts by @drjimmy2407
#SME Good results Good Guidance
1. #TaurianMPS - 45/50% CAGR
2. #TIPCO - 45-50cr PAT FY27E
3. #Prizor - 60/70% conservative
4. #PPEL #PoojaPrecision - 50% FY27vs FY26
5. #Zelio - 65-70cr PAT FY27E
6. #TechnocratsPlasma - 50/60% growth
7. #ApsisAerocom - 10/12 cr PAT FY27E
11
1,883
Interesting case study of V2 Retail vs Baazar Style Retail
During Q1, most retail Investors were Bullish on V2 and bearish on Baazar Style. I was also on similar lines, though never invested in any of them.
Fast forward to Q3, Baazar Style has doubled and is making daily all time high. V2 has corrected by 40% from top and is at 52 week low.
What has changed
Baazar Style upgraded it's guidance and store opening strategy in Q2.
Ace investor Aditya Halwasiya invested heavily in Baazar Style.
V2 Retail SSSG struggled with low single digit and PAT remained flat due to high depreciation cost.
Can this situation reverse in coming quarters, like it did in last quarter?
Baazar Style always falls behind V2 Retail though it still continues to grow at healthy rate.
However share price since it got listed 2 year ago, has given -30% returns.
Whereas V2 Retail has been more than 3X in last 2 years.
Huge assymetry of returns between fastest growing and 2nd fastest growing player in same space.
Apollo Micro Systems journey has been stupendous in last 5 years.
Can following micro cap defence companies do what Apollo has done in last 5 years. Time will tell.
Krishna Defence
Shree Refrigerations
Jaykay Enterprise
CFF Fluid
C2C Adavance
Apollo Micro Systems (APOLLO) —
From ₹300 Cr market cap (around FY20-21) to ₹10,000 Cr today.
That's 3000%+ returns in 5 years.
A classic Indian defence small-cap story powered by Atmanirbhar Bharat + sharp execution.
Business Didn't Change-- Scale Did
Apollo has always made high-reliability defence electronics:
• Embedded systems
• Missile electronics, fuzing, fire control
• Avionics, inertial navigation
• Naval (torpedoes, smart mines)
• Now expanding into cybersecurity & anti-drone
They shifted from small custom jobs to larger system integration & high-value platforms.
700+ onboard technologies, 150+ indigenous programs.
The Real Catalyst: India's Defence Indigenization Boom:
Negative import lists
Make in India + iDEX
Rising defence budget
Apollo, already a DRDO & DPSU partner, became a direct winner.
Consistent L1 wins in strategic programs gave multi-year visibility.
Recent orders (2025-26):
₹73 Cr+ from DRDO/DPSUs (torpedo homing, missile launchers, fire control, cybersecurity)
Multiple ₹25-150 Cr wins
Order book: ~₹1,305 Cr (as of Dec 2025) — healthy & growing.
They Built Capacity Aggressively
This is key -they didn't just win orders, they invested to deliver them.
Massive ~700% capacity expansion
New Integrated Plant for missile manufacturing & MRO in Hyderabad
₹210-300 Cr+ capex in recent phases (Unit-II done, Unit-III progressing)
Fresh ₹300 Cr greenfield project on 5+ acres in Telangana for weapon system platforms (integration, testing of rockets, mines, munitions etc.
Today Co is granted lifetime arms manufacture license by govt for missles, ATGMS, Torpedoes, Loitering Munition.
CFF Fluid Control has won domestic supply contracts from Mazagon Dock Shipbuilders, Naval Dockyard and Naval Group India ~ worth Rs 15.29 crore, to be executed by February 2028.
1
5
660
Exited FCL today completely. I was holding 70% of position, 30% I sold much earlier in mid 50s.
Fineotex Chemical management in the Concall
After entry into Oil and Gas segment, next big opportunity is Water Treatment Chemistry as a segment. Water treatment solutions will cater to most sectors.
NDA has been signed with few reputed customers and revenue should start showing from Q4 onwards.
3
52
5,812
Tushar Sarkar retweeted
The guy starts a company, invents a new technology, then is dethroned by a board composed of virtue faking empty suits who never did anything other than powerpoint presentations, while the Epstein crowd is enjoying champagne parties.
His personal life is none of their business.
JUST IN: Jensen Huang discusses returning as Nvidia $NVDA CEO with allies.
Fineotex Chemical management in the Concall
After entry into Oil and Gas segment, next big opportunity is Water Treatment Chemistry as a segment. Water treatment solutions will cater to most sectors.
NDA has been signed with few reputed customers and revenue should start showing from Q4 onwards.
Indian Mining Sector is at sweetest spot ever to benefit from ongoing and upcoming manufacturing boom and commodity supercycle.
I believe MSTC is also going to big beneficiary of this theme as a government backed e-auction platform for auction of mining blocks.
Very important sector to track and keep a watch. Excellent thread.
RBi granted in-principle authorisation to MSTC on 11 November 2026 for a trade receivables discounting network, adding a new recurring fee stream alongside sovereign auctions for commercial coal mines and state land parcels.
MSTC Q2 Concall notes
Diversification: Exploring dedicated Coal and Mineral Exchanges to expand sector footprint.
Digital Initiatives: B2B Travel Portal operational; enhancements for B2C underway.
Management hoped approval for operationalizing the EPR platform would come during the fiscal from GoI, while saying it did not have a firm timing outlook.
Financial Technologies: Developing Trade Receivables Discounting System (TREDS) with in principal approval from RBI, subject to conditions and final authorization.
Regulatory Dependence: Coal Exchange expansion subject to approvals from Ministry of Coal and authorities.
Growth Strategy: Targets double-digit 10-20% growth on conservative basis.
This Post is from an account that no longer exists. Learn more
2
337
Fineotex Chemical
Very good Q2FY27 Results YoY and flat QoQ
Revenue growth of 182%
PAT growth 71%
OCF at -11cr vs 18cr
PAT growth is lagging behind because Crudechem's 100% revenue is reflected in Consolidated statement but only 51% of PAT is reflected which is in proportion to the acquired stake.
Fineotex Chemical
✅ Credit Rating upgrade
➤ ICRA upgraded Fineotex's long-term rating to AA- from A+ reflecting improved scale and diversification after acquisition of US speciality chemical group, strong financial profile with negligible debt, and healthy liquidity.
✅ Short-term rating A1+ reaffirmed.
➤ Outlook revised to stable from positive.
The GoI approved a five-year continuation of the Credit Guarantee Fund for Micro Units (CGFMU) through March 31, 2031, backed by a ₹5,000 crore corpus. Managed by the National Credit Guarantee Trustee Company Limited (NCGTC), the scheme covers collateral-free Mudra loans up to ₹20 lakh, Jan Dhan overdrafts up to ₹10,000, and Self Help Group (SHG) portfolios.
The NCGTC lists 15 NBFC-MFIs and 10 Small Finance Banks as registered Member Lending Institutions (MLIs) under the fund:
Below are the listed registered NBFC-MFIs:
▪️Satin Creditcare Network,
▪️Svatantra Microfin (IPO bound)
Registered (listed) Small Finance Banks:
▪️AU SFB
▪️Equitas SFB
▪️ESAF SFB
▪️Jana SFB
▪️Suryoday SFB
▪️Ujjivan SFB
▪️Utkarsh SFB
The Cabinet approval for continuation of the Credit Guarantee Fund for Micro Units is a major boost for India's aspiring entrepreneurs, especially our youth!
What does this mean?
Rs. 5,000 crore corpus to help facilitate over Rs 12.5 lakh crore in MUDRA loans over the next 5 years.
Credit guarantee support for collateral-free loans up to Rs. 20 lakh under PM MUDRA Yojana.
Lower guarantee fees to encourage lending to micro-enterprises.
Our aim is to empower more young Indians to turn their ideas into enterprises, create opportunities and become job creators.
pib.gov.in/PressReleaseDetai…
Medical Device PLI Scheme extended by 8 years: Major push for domestic manufacturing and component localisation
Medical Device PLI Scheme extended by 8 years: Major push for domestic manufacturing and component localisation
The government has extended the Production Linked Incentive (PLI) scheme for medical devices until FY2035-36, with a clear shift towards manufacturing high-end medical equipment and critical components in India.
The Department of Pharmaceuticals has extended the medical devices PLI scheme by eight years.
The scheme was originally announced in Mar'20 and extended until FY35-36. Approximately Rs. 2,700 CR remains available under the existing scheme. New applicants can get up to three years to establish manufacturing facilities.
The government wants to increase domestic manufacturing of:
=> MRI machines.
=> CT scanners.
=> PET-CT scanners.
=> Ultrasound equipment.
=> High-end medical devices.
=> Critical medical electronics and components
India currently depends significantly on imports for several high-end medical equipment categories. The policy aims to reduce this dependence by developing domestic manufacturing capabilities.
Four target segments:
TS1 - Medical consumables, disposables and implants
TS2 - Critical components
TS3 - High-end medical devices that are currently at a nascent stage
TS4 - High-end medical devices that are presently only assembled in India
The revised framework introduces different incentive rates across the target segments.
TS1: 5%
TS2: 9%
TS3: 6%
TS4: 3%
The government has reduced the minimum investment requirement, including the previously cited Rs. 180 CR threshold.
Other changes include three years to establish manufacturing facilities, more flexibility in manufacturing timelines, revised incentive framework and tapering incentive rates instead of the earlier flat-rate structure.
The biggest opportunity is in reducing India's dependence on imported medical equipment while developing domestic capabilities in advanced imaging, medical electronics and precision components.
Hindustan Copper — Excellent Q2FY27 Results on YoY & QoQ basis aided by rising copper price
Revenue ₹1175 Cr (up 64% YoY & 25% QoQ)
EBITDA Margin 59.80% vs 39.29% YoY & 54.19% QoQ
PAT ₹518 Cr (up 180% YoY & 47% QoQ)
OCF ₹843 Cr vs ₹428 Cr
2
8
1,185
Redington India
✅ ICICI Direct initiates buy with TP of 500 in 1 year
💡Investment rationale
➤ The company has 73,000+ channel partners, ~450 brands, 168 warehouses and 71 sales offices across 40 markets through 33 in-country operations.
➤ Leadership market position and strong vendor relationship
➤ Play on premiumisation trend
➤ Diversified play with SSG and TSG emerging as key value drivers
Redington Ltd. ~ Blockbuster Q1FY27 in company's history
Shifting product mix from low margin distribution business to high margin Al services business has started to bear fruits
Revenue 34922 Cr; 35% YoY & 5% QoQ
PAT 453 Cr; 95% YoY & 58% QoQ
Such big jump might be due to jump in laptop and memory device prices.




























